Want to see OTSKY full AI Analyst Report?
OTSKY Stock Chart & Stats
$37.96
$0.33(0.98%)
At close: 4:00 PM EDT
$37.96
$0.33(0.98%)
Day’s Range― - ―
52-Week Range$26.42 - $40.22
Previous CloseN/A
Volume30.27K
Average Volume (3M)1.67K
Market Cap
$40.87B
Enterprise Value$33.72B
Total Cash (Recent Filing)$505.94B
Total Debt (Recent Filing)$194.20B
Price to Earnings (P/E)16.0
Beta0.14
Next Earnings
Oct 30, 2026EPS Estimate
0.59Next Dividend Ex-DateN/A
Dividend Yield1.1%
Share Statistics
EPS (TTM)389.53
Shares Outstanding1,085,977,800
10 Day Avg. Volume0
30 Day Avg. Volume1,674
Financial Highlights & Ratios
PEG Ratio0.93
Price to Book (P/B)1.55
Price to Sales (P/S)1.82
P/FCF Ratio14.23
Enterprise Value/Market Cap0.82
Enterprise Value/Revenue0.01
Enterprise Value/Gross Profit0.02
Enterprise Value/Ebitda0.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.24
Revenue Forecast (FY)$17.48B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and steadily growing equity provide durable financial flexibility. This minimizes refinancing and interest risks, supports sustained R&D and capex funding, and creates capacity for opportunistic M&A or shareholder returns without stressing earnings power.
Improving ProfitabilityA material step-up to ~15% net margin alongside accelerating revenue growth indicates structural improvement in product mix, pricing, or cost efficiency. Sustained higher margins enhance free cash generation and long-term return on invested capital, strengthening reinvestment potential.
Rising Free Cash FlowConsistently positive and rising free cash flow supports durable self-funding of operations, dividends, and strategic investments. Reliable FCF reduces reliance on external financing and increases operational resilience through product cycles and regulatory lags.
Bears Say
Weak Cash ConversionCash covers only ~55% of reported earnings, implying working-capital timing or non-cash profit components. Persistently weak conversion erodes earnings quality, limits internal funding for growth, and raises sensitivity to receivables or inventory swings over medium term.
Profitability VolatilityA notable earnings trough in 2022–2023 shows operating results can be cyclical or product-lifecycle dependent. Such durability risks complicate forecasting, capital allocation, and investor confidence if product competition, pricing, or reimbursement pressures re-emerge.
Negative EPS GrowthNegative EPS growth indicates recent per-share earnings deterioration versus prior periods. This suggests either operational headwinds or share-count/effect dynamics and signals that margin and cash improvements must be sustained to re-establish consistent multi-period EPS momentum.
Otsuka Holdings Co News
OTSKY FAQ
What was Otsuka Holdings Co Ltd’s price range in the past 12 months?
Otsuka Holdings Co Ltd lowest stock price was $26.42 and its highest was $40.22 in the past 12 months.
What is Otsuka Holdings Co Ltd’s market cap?
Otsuka Holdings Co Ltd’s market cap is $40.87B.
When is Otsuka Holdings Co Ltd’s upcoming earnings report date?
Otsuka Holdings Co Ltd’s upcoming earnings report date is Oct 30, 2026 which is tomorrow.
How were Otsuka Holdings Co Ltd’s earnings last quarter?
Otsuka Holdings Co Ltd released its earnings results on Jul 31, 2026. The company reported $0.7 earnings per share for the quarter, beating the consensus estimate of $0.506 by $0.194.
Is Otsuka Holdings Co Ltd overvalued?
According to Wall Street analysts Otsuka Holdings Co Ltd’s price is currently Overvalued.
Does Otsuka Holdings Co Ltd pay dividends?
Otsuka Holdings Co Ltd pays a Semiannually dividend of $0.321 which represents an annual dividend yield of 1.1%. See more information on Otsuka Holdings Co Ltd dividends here
What is Otsuka Holdings Co Ltd’s EPS estimate?
Otsuka Holdings Co Ltd’s EPS estimate is 0.59.
How many shares outstanding does Otsuka Holdings Co Ltd have?
Otsuka Holdings Co Ltd has 1,085,977,800 shares outstanding.
What happened to Otsuka Holdings Co Ltd’s price movement after its last earnings report?
Otsuka Holdings Co Ltd reported an EPS of $0.7 in its last earnings report, beating expectations of $0.506. Following the earnings report the stock price went down -1.753%.
Which hedge fund is a major shareholder of Otsuka Holdings Co Ltd?
Currently, no hedge funds are holding shares in OTSKY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Otsuka Holdings Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.20%
12-Months-Change
Fundamentals
Return on Equity
13.24%
Trailing 12-Months
Asset Growth
3.10%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Otsuka Holdings Co Ltd
Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
OTSKY Company Deck
OTSKY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong overall performance in both pharmaceutical and nutraceutical segments with significant revenue and profit growth, and positive strategic expansions such as the acquisition for drug discovery. However, there were challenges such as impairment losses and increased SG&A expenses.View all OTSKY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.01% Other Institutional Investors
99.98% Public Companies and
Individual Investors